Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology

I Janszky1, K J Mukamal, R Ljung

  • 1Department of Public Health Sciences, Karolinska Institute, Stockholm, Sweden. imre.janszky@ki.se

Insights

Regular chocolate consumption may lower cardiac mortality in heart disease patients. This study found a dose-dependent inverse relationship between chocolate intake and cardiac death risk in survivors of a first acute myocardial infarction.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Epidemiology

Background:

  • Established coronary heart disease (CHD) patients face long-term risks.
  • Understanding dietary impacts on cardiac health is crucial.

Purpose of the Study:

  • To investigate the long-term effects of chocolate consumption on patients with existing coronary heart disease.
  • To determine if chocolate intake influences cardiac mortality or other adverse cardiovascular outcomes.

Main Methods:

  • A population-based inception cohort study followed 1169 non-diabetic patients post-first acute myocardial infarction (AMI).
  • Chocolate consumption was self-reported via questionnaire during hospitalization.
  • Participants were monitored for 8 years using national registries for mortality and hospitalizations.

Main Results:

  • Chocolate consumption showed a significant inverse association with cardiac mortality in a dose-dependent manner.
  • Patients consuming chocolate twice or more per week had a 66% lower cardiac mortality risk compared to non-consumers (HR 0.34).
  • No significant association was found between other sweets intake and mortality.

Conclusions:

  • Chocolate consumption is linked to reduced cardiac mortality in diabetic-free patients after their first AMI.
  • Findings suggest chocolate's bioactive compounds may offer cardiovascular benefits.
  • Further confirmation through observational studies and randomized controlled trials is warranted.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...